Zhentao Mo

453 total citations
14 papers, 376 citations indexed

About

Zhentao Mo is a scholar working on Pharmacology, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhentao Mo has authored 14 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Zhentao Mo's work include Medicinal Plant Pharmacodynamics Research (5 papers), Cancer-related molecular mechanisms research (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Zhentao Mo is often cited by papers focused on Medicinal Plant Pharmacodynamics Research (5 papers), Cancer-related molecular mechanisms research (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Zhentao Mo collaborates with scholars based in China. Zhentao Mo's co-authors include Yu‐Ping He, Yongqi Fang, Sheng Zhang, Yiqi Li, Wenna Li, Qihai Gong, Shuying Gao, Yang Chen, Canhui Xiang and Yan Lin and has published in prestigious journals such as Life Sciences, Phytotherapy Research and Journal of Functional Foods.

In The Last Decade

Zhentao Mo

14 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhentao Mo China 10 153 84 72 62 53 14 376
Zhirui Fang China 12 212 1.4× 76 0.9× 60 0.8× 31 0.5× 34 0.6× 19 399
Jiangyan Xu China 14 258 1.7× 91 1.1× 45 0.6× 36 0.6× 93 1.8× 30 506
Jie‐Jian Kou China 8 177 1.2× 43 0.5× 50 0.7× 85 1.4× 25 0.5× 14 420
Xiaodi Fan China 10 187 1.2× 96 1.1× 80 1.1× 68 1.1× 52 1.0× 21 489
Jian-Hua Fu China 12 222 1.5× 75 0.9× 55 0.8× 48 0.8× 59 1.1× 37 506
Tian Xu China 13 171 1.1× 75 0.9× 56 0.8× 78 1.3× 23 0.4× 19 385
Zhongpeng Lu China 12 187 1.2× 106 1.3× 33 0.5× 25 0.4× 31 0.6× 17 418
Yuxuan Kan China 14 236 1.5× 95 1.1× 57 0.8× 28 0.5× 50 0.9× 25 580

Countries citing papers authored by Zhentao Mo

Since Specialization
Citations

This map shows the geographic impact of Zhentao Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhentao Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhentao Mo more than expected).

Fields of papers citing papers by Zhentao Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhentao Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhentao Mo. The network helps show where Zhentao Mo may publish in the future.

Co-authorship network of co-authors of Zhentao Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhentao Mo. A scholar is included among the top collaborators of Zhentao Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhentao Mo. Zhentao Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
3.
Li, Wenna, Xu Li, Zhentao Mo, et al.. (2022). Gardenia fruit and Eucommia leaves combination improves hyperlipidemia and hyperglycemia via pancreatic lipase and AMPK-PPARα and Keap-1-Nrf2-HO-1 regulation. Journal of Functional Foods. 100. 105394–105394. 4 indexed citations
4.
Xu, Yuanyuan, et al.. (2022). Icariin attenuates ischaemic stroke through suppressing inflammation mediated by endoplasmic reticulum stress signalling pathway in rats. Clinical and Experimental Pharmacology and Physiology. 49(7). 719–730. 9 indexed citations
5.
Mo, Zhentao, et al.. (2021). Icariin inhibits the expression of IL-1β, IL-6 and TNF-α induced by OGD/R through the IRE1/XBP1s pathway in microglia. Pharmaceutical Biology. 59(1). 1471–1477. 25 indexed citations
7.
Mo, Zhentao, Yiqi Li, Yueyue Zhang, et al.. (2018). Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells. BMC Complementary and Alternative Medicine. 18(1). 122–122. 55 indexed citations
8.
Li, Wenna, Qiang Xie, Zhentao Mo, et al.. (2017). In vitro evaluation of ruthenium complexes for photodynamic therapy. Photodiagnosis and Photodynamic Therapy. 18. 83–94. 13 indexed citations
9.
10.
Mo, Zhentao, et al.. (2016). Icariin Attenuates OGD/R‐Induced Autophagy via Bcl‐2‐Dependent Cross Talk between Apoptosis and Autophagy in PC12 Cells. Evidence-based Complementary and Alternative Medicine. 2016(1). 4343084–4343084. 40 indexed citations
11.
Lin, Yan, Zhentao Mo, Yang Chen, et al.. (2015). Chlorogenic acid-enriched extract fromEucommia ulmoidesleaves inhibits hepatic lipid accumulation through regulation of cholesterol metabolism in HepG2 cells. Pharmaceutical Biology. 54(2). 251–259. 67 indexed citations
12.
He, Yu‐Ping, et al.. (2013). Establish a flow cytometric method for quantitative detection of Beclin-1 expression. Cytotechnology. 65(4). 481–489. 16 indexed citations
13.
Mo, Zhentao, Yongqi Fang, Yu‐Ping He, & Sheng Zhang. (2012). β-Asarone protects PC12 cells against OGD/R-induced injury via attenuating Beclin-1-dependent autophagy. Acta Pharmacologica Sinica. 33(6). 737–742. 64 indexed citations
14.
Mo, Zhentao, et al.. (2012). Change of Beclin‐1 dependent on ATP, [Ca2+]i and MMP in PC12 cells following oxygen‐glucose deprivation‐reoxygenation injury. Cell Biology International. 36(11). 1043–1048. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026